Followers | 3 |
Posts | 251 |
Boards Moderated | 0 |
Alias Born | 04/23/2013 |
Thursday, June 28, 2018 1:07:34 PM
Source: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=139862094
Also, to protect themselves from lawsuits, the gov requires high standards for acceptance of Nyloxin: double-blind, placebo-controlled, published and peer-reviewed. In spite of being an awesome product, none of Nyloxin’s studies meet those requirements.
Thinking
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM